Drug Profile
Research programme: neurotensin derivatives - Argolyn Bioscience
Alternative Names: ABS 201; ABS 212Latest Information Update: 30 Dec 2009
Price :
$50
*
At a glance
- Originator Argolyn Bioscience
- Class
- Mechanism of Action Neurotensin type 2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain; Schizophrenia
Most Recent Events
- 26 Jun 2007 Preclinical trials in Pain in USA (unspecified route)
- 26 Jun 2007 Preclinical trials in Schizophrenia in USA (unspecified route)